DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Chris Luxon - 1 Luxon - 1 Christopher Luxon - 1 Marty Melville - 1 Rishi Sunak - 1 ” - 1 Nicola Willis - 1 Saturday - 1
Top related locs:
New Zealand ACT New Zealand Wellington AFP Britain Los Angeles , California Radio New Zealand New
Top related orgs:
CNN - 1 National Party - 1 New Zealand First - 1 ACT New - 1 Radio New Zealand - 1 Government House - 1 Getty - 1 British - 1

Search resuls for: "World Health Organization –"


3 mentions found


☆ New Zealand’s new government scraps world-leading smoking ban to fund tax cuts
  + stars: | 2023-11-28 | by ( Heather Chen | ) edition.cnn.com   time to read: +4 min
A year after passing a world-leading smoking ban designed to save thousands of lives and prevent new generations of young adults from smoking, New Zealand has announced a u-turn to help pay for tax cuts, infuriating public health officials and anti-tobacco groups. Marty Melville/AFP/Getty ImagesNew Zealand’s initial smoking ban was hailed by public health officials around the world. Months after New Zealand’s announcement, Britain also unveiled plans to phase out smoking for new generations. A spokesperson for British Prime Minister Rishi Sunak said that the British government remained committed to phasing out smoking, even after New Zealand’s reversal. The anti-smoking group Health Coalition Aotearoa (HCA) expressed disappointment at the new coalition’s plans to repeal the smoking ban.
Persons: Chris Luxon, Luxon, Christopher Luxon, Marty Melville, Rishi Sunak, ”, Nicola Willis, Saturday, Mario Tama, Ayeshea Verrall, “ What’s, ” Verrall Organizations: CNN, National Party, New Zealand First, ACT New, Radio New Zealand, Government House, Getty, British, World Health, Radio New, Health Coalition Aotearoa, New Zealanders Locations: New Zealand, ACT New Zealand, Wellington, AFP, Britain, Los Angeles , California, Radio New Zealand, New
☆ Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
  + stars: | 2023-09-13 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +2 min
Wednesday's results are also a sigh of relief for Moderna after the company pushed back its experimental flu shot program in April. Moderna compared the flu vaccine, dubbed mRNA-1010, to a currently approved seasonal flu vaccine from GlaxoSmithKline called Fluarix. Moderna's flu shot also generated higher seroconversion rates, which refers to the development of specific antibodies against a virus. Also on Wednesday, Moderna said it is ending a separate phase three trial on the first version of its flu vaccine. "With today's positive phase 3 flu results, along with previous results in Covid and RSV, we are now three for three on advancing respiratory disease programs to positive phase 3 data."
Persons: Moderna, Stephane Bancel Organizations: Moderna, U.S, GlaxoSmithKline, World Health Organization –, Food and Drug Administration, FDA, Pfizer, GSK Locations: Moderna, Covid
☆ The Covid-19 emergency may end, but there’s no rule to say when the pandemic is over
  + stars: | 2022-09-21 | by ( Brenda Goodman | ) edition.cnn.com   time to read: +7 min
For now, it remains a public health emergency in the United States, according to the US Department of Health and Human Services, and it’s still a public health emergency of international concern, or PHEIC, according to WHO. Each country, in turn, declares its own public health emergency – declarations that carry legal weight. In the United States, for example, the end of the public health emergency will have ramifications for health care coverage and cost-sharing of Covid-19 tests and treatments. At this point, WHO is not saying whether it will recognize an end to the Covid-19 pandemic. Instead, he said, WHO will continue to assess the need for the public health emergency, and an expert committee meets every three months to do that.
0 next >>
Total: 3